| Analysis | Metabolite Name | Measured Value | Units | Cage # | Organ | Treatment |
|---|---|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.105674753 | normalized imputed data | 1 | Cecum | Amox |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.251471409 | normalized imputed data | 3 | Cecum | Control |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.276216514 | normalized imputed data | 4 | Cecum | Control |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.280441647 | normalized imputed data | 2 | MSI | Amox |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.317638767 | normalized imputed data | 3 | Cecum | Control |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.34418698 | normalized imputed data | 2 | Cecum | Amox |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.370723916 | normalized imputed data | 1 | Cecum | Amox |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.385946084 | normalized imputed data | 1 | Colon | Amox |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.386015584 | normalized imputed data | 4 | Cecum | Control |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.391221332 | normalized imputed data | 1 | Cecum | Amox |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.411470976 | normalized imputed data | 2 | DSI | Amox |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.418011536 | normalized imputed data | 3 | Colon | Control |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.434840908 | normalized imputed data | 4 | Cecum | Control |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.446823768 | normalized imputed data | 4 | DSI | Control |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.448739485 | normalized imputed data | 1 | DSI | Amox |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.478642764 | normalized imputed data | 3 | Cecum | Control |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.523126911 | normalized imputed data | 3 | Colon | Control |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.535994494 | normalized imputed data | 2 | Cecum | Amox |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.539372975 | normalized imputed data | 1 | DSI | Amox |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.606409026 | normalized imputed data | 1 | Colon | Amox |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.614910014 | normalized imputed data | 2 | DSI | Amox |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.622387337 | normalized imputed data | 1 | MSI | Amox |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.62426607 | normalized imputed data | 2 | Colon | Amox |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.655487847 | normalized imputed data | 4 | Colon | Control |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.754549734 | normalized imputed data | 3 | DSI | Control |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.771632889 | normalized imputed data | 2 | DSI | Amox |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.780317761 | normalized imputed data | 3 | DSI | Control |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.826193969 | normalized imputed data | 1 | Colon | Amox |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.85185122 | normalized imputed data | 3 | MSI | Control |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.86050283 | normalized imputed data | 2 | MSI | Amox |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.885248164 | normalized imputed data | 4 | DSI | Control |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.906541282 | normalized imputed data | 2 | Cecum | Amox |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.942303918 | normalized imputed data | 2 | Colon | Amox |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.942426774 | normalized imputed data | 1 | DSI | Amox |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.963863872 | normalized imputed data | 4 | Colon | Control |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 1 | normalized imputed data | 4 | DSI | Control |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 1.002003593 | normalized imputed data | 4 | Colon | Control |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 1.096455006 | normalized imputed data | 2 | Colon | Amox |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 1.123725871 | normalized imputed data | 1 | Stomach | Amox |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 1.161289841 | normalized imputed data | 3 | DSI | Control |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 1.317093643 | normalized imputed data | 1 | MSI | Amox |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 1.616032892 | normalized imputed data | 3 | MSI | Control |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 2.049467712 | normalized imputed data | 2 | Stomach | Amox |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 2.32333027 | normalized imputed data | 1 | Stomach | Amox |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 2.700706954 | normalized imputed data | 4 | Stomach | Control |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 3.113356167 | normalized imputed data | 4 | MSI | Control |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 3.25950393 | normalized imputed data | 1 | MSI | Amox |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 3.678201593 | normalized imputed data | 4 | Stomach | Control |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 3.832893109 | normalized imputed data | 2 | MSI | Amox |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 3.854607406 | normalized imputed data | 1 | Stomach | Amox |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 4.040826865 | normalized imputed data | 2 | PSI | Amox |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 4.173587455 | normalized imputed data | 3 | Stomach | Control |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 4.203845619 | normalized imputed data | 3 | MSI | Control |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 5.105356793 | normalized imputed data | 4 | PSI | Control |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 5.343648441 | normalized imputed data | 2 | PSI | Amox |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 5.407773448 | normalized imputed data | 4 | MSI | Control |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 5.570659213 | normalized imputed data | 1 | PSI | Amox |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 5.582972456 | normalized imputed data | 3 | Stomach | Control |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 6.63932279 | normalized imputed data | 4 | MSI | Control |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 7.038576071 | normalized imputed data | 3 | PSI | Control |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 7.569340773 | normalized imputed data | 2 | Stomach | Amox |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 8.440931092 | normalized imputed data | 1 | PSI | Amox |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 8.748244065 | normalized imputed data | 4 | PSI | Control |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 8.985962423 | normalized imputed data | 2 | Stomach | Amox |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 9.004382395 | normalized imputed data | 3 | Stomach | Control |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 9.297960294 | normalized imputed data | 3 | PSI | Control |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 9.670052456 | normalized imputed data | 1 | PSI | Amox |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 9.86333321 | normalized imputed data | 4 | Stomach | Control |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 10.71837416 | normalized imputed data | 4 | PSI | Control |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 12.15603286 | normalized imputed data | 2 | PSI | Amox |
| Reversed phase POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 13.0291429 | normalized imputed data | 3 | PSI | Control |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|